Continued Breast Cancer Risk Reduction in Postmenopausal Women Treated with Raloxifene: 4-Year Results from the MORE Trial

Jane A. Cauley, Larry Norton, Marc E. Lippman, Stephen Eckert, Kathryn A. Krueger, David W. Purdie, Jordi Farrerons, Avraham Karasik, Dan Mellstrom, Kong Wah Ng, Jan J. Stepan, Trevor J. Powles, Monica Morrow, Alberto Costa, Sheryl L. Silfen, Erin L. Walls, Henry Schmitt, Douglas B. Muchmore, V. Craig Jordan
  • Breast Cancer Research and Treatment, January 2001, Springer Science + Business Media
  • DOI: 10.1023/a:1006478317173

The authors haven't yet claimed this publication.

Read Publication

In partnership with: